吴文新, 陈彦亮, 刘增良, 和宇峥, 崔爱荣, 李书军. hsa-miR-223表达载体构建及其对靶基因ARTN的调控[J]. 中国肿瘤临床, 2011, 38(9): 503-507 . DOI: 10.3969/j.issn.1000-8179.2011.09.006
引用本文: 吴文新, 陈彦亮, 刘增良, 和宇峥, 崔爱荣, 李书军. hsa-miR-223表达载体构建及其对靶基因ARTN的调控[J]. 中国肿瘤临床, 2011, 38(9): 503-507 . DOI: 10.3969/j.issn.1000-8179.2011.09.006

hsa-miR-223表达载体构建及其对靶基因ARTN的调控

  • 摘要: 目的:构建hsa-miR-223真核表达载体, 并在人食管癌细胞KYSE-150中验证hsa-miR-223对靶基因artemin (ARTN)的调控作用。方法: 以基因组DNA为模板, RT-PCR扩增包括hsa-miR-223前体序列在内的基因序列, 并将其克隆到载体pCD?NA3.1 (+) 上, 通过实时定量PCR方法检测hsa-miR-223在人胚肾HEK293细胞中的表达。根据生物信息学预测软件TargetScan、mirBase和PicTar对hsa-miR-223靶基因进行预测, 将靶基因ARTN的3'UTR区融合到pMIR荧光素酶基因下游, 通过双荧光素酶报告基因检测hsa-miR-223对靶基因ARTN的3'UTR区的调控作用。将pCDNA3.1-miR-223表达质粒转染人食管癌细胞KYSE150, 通过Western blot检测对ARTN蛋白表达的影响。结果: 成功构建hsa-miR-223表达载体pCDNA3.1-miR-223。实时定量 PCR 验证表明 pCDNA3.1-miR-223 在人胚肾 HEK293 中能够明显地过表达成熟 miR-223。生物信息学预测 ARTN 是hsa-miR-223的靶基因, 并构建融合ARTN的3'UTR区表达质粒pMIR-ARTN, 在此基础上对ARTN的3'UTR “种子区” 进行定点突变。双荧光素酶报告基因分析表明hsa-miR-223能够作用于ARTN的3'UTR。Western blot法进一步证实ARTN是miR-223的靶基因。结论: hsa-miR-223作用于ARTN的3'UTR可在转录后水平上调控ARTN蛋白的表达。

     

    Abstract: Construction of miR-223 Expression Vector and Its Regulation to Target Gene ArteminWenxinWU1, Yanliang CHEN2, Zengliang LIU2, Yuzheng HE3, Airong CUI1, Shujun LI3Correspondence to: Shujun LI, E-mail: lsj821@sina.com1Department of Pathology, The Second Hospital of Hebei Medical University, Shijiazhuang 050051, China2Shexian Hospital, Handan 056400, China3Department of Thoracic Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang 050051, ChinaAbstract Objective: To construct a eukaryotic expression vector of hsa-miR-223 and to verify the regulatory effect ofhsa-miR-223 on target gene artemin in human esophageal carcinoma cell KYSE150. Methods: PCR primers were designed andmiR-223 precursor sequence was amplified from genomic DNA. PCR product was cloned to the linearized pMD18-T Simple vectorand then was subcloned into pCDNA3.1 ( + ) by BamHⅠand EcoRⅠdouble-ligated. The recombinant plasmid pCDNA3.1 (+ )-miR-223 was analyzed through restriction enzyme digestion and sequencing analysis. Mature miR-223 expression was higher inKYSE150 cells transfected with pCDNA3.1 ( + )-miR-223 than that in KYSE150 cells transfected with pCDNA3.1 ( + ) by real-timePCR. Software and websites of bioinformatics including TargetScan, PicTar and MirBase were used for target gene prediction. Recom-bined vector pMIR-ARTN was constructed to express artemin 3'UTR, and mutation expression vector pMIR-ARTN-Mut was also con-structed. Co-transfection of both recombined vectors were performed in HEK293 cells and dual-luciferase reporter assay was analyzed.Western blot was used to detect the expression of artemin protein in KYSE150 cell line transfected with pCDNA3.1(+)-miR-223 andpCDNA3.1 ( + ). Results: Eukaryotic expression vector pCDNA3.1(+)-miR-223 was successfully constructed and it expressed maturemiR-223 in human esophageal carcinoma KYSE150 cells transfected with pCDNA3.1 ( + )-miR-223. Artemin was selected as a candi-date of target genes which has 7 base pairs completely matched to miR-223 in the 3’ UTR seed zone. Recombined vector pMIR-ARTNfused ARTN 3'UTR and mutation expression vector pMIR-ARTN-Mut were constructed. Dual-luciferase reporter assay showed thatmiR-223 decreased the activity of luciferase co-transfected with pMIR-ARTN. Overexpression of exogenous miR-223 in KYSE150 cellline significantly suppressed the expression of artemin protein. Conclusion: MiR-223 can suppress artemin gene expression at thepost-transcriptional level by targeting the specific sequence of artemin 3'UTR.Keywords Hsa-miR-223; Eukaryotic expression vector; Reporter gene

     

/

返回文章
返回